Peppermint for IBS
Peppermint oil is a natural antispasmodic and encourages the bowel muscles to relax. Peppermint has a long history of use for relieving the symptoms of irritable bowel syndrome.
Help Relieve Abdominal Discomfort, Cramping, Pain & Bloating
Studies have shown that peppermint oil helps reduce abdominal discomfort, pain and symptoms associated with Irritable Bowel Syndrome, in particular bloating, cramping & spasms (1,2).
Mintec IBS Relief capsules are enteric-coated, meaning the capsules pass through the stomach intact, delaying the release of the peppermint oil until the capsule reaches the bowel where it is needed to work (3).
It is FODMAP Friendly approved and displays the FODMAP Friendly certification on front of pack. To read more about irritable Bowel Syndrome, click here.
Suggested use of Mintec for IBS
ADULTS: Take 1 or 2 capsules three times daily before meals, depending on the severity of your symptoms. Swallow the capsules whole with water 30 mins before meals (do not bite or chew the capsule)
Do not break or chew the capsules. Do not take immediately after a meal, or with a hot drink.
Not recommended children or for use during pregnancy and breastfeeding. Mintec may cause heartburn. If you develop the symptom, stop taking and ask your healthcare professional for advice. Peri-anal itching or burning has been reported on occasion. Always read the label and use as directed. Do not exceed the recommended daily dose. If symptoms persist, consult your healthcare professional. Store below 25oC. Protect from light and moisture. Do not use if blister seal is broken.
Each Mintec enteric-coated capsule contains: 0.2 mL of pure peppermint oil. Comes in two sizes, 20 & 60 capsules.
- Khanna, Reena MD*; MacDonald, John K. MA*; Levesque, Barrett G. MD, MS† Peppermint Oil for the Treatment of Irritable Bowel Syndrome, Journal of Clinical Gastroenterology: July 2014 – Volume 48 – Issue 6 – p 505-512. doi: 10.1097/MCG.0b013e3182a88357
- Alammar, N., Wang, L., Saberi, B. et al. The impact of peppermint oil on the irritable bowel syndrome: a meta-analysis of the pooled clinical data. BMC Complement Altern Med 19, 21 (2019). https://doi.org/10.1186/s12906-018-2409-0